
Lorlatinib
MedicationWikipedia
2
MENTIONS
2
EPISODES
2
PODCASTS
Search complete. 2 mentions across 2 episodes found for "Lorlatinib".
Oct 4, 2026
Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
S
24:10Stephen LiuGUEST
It's got frontline data, high response rates, 70, 80%, durable response rates, some CNS efficacy.
S
24:16Stephen LiuGUEST
And so it feels like a frontline drug to me, but if I had to sort of slot it, is it like an EGFR OC or is it like a Lorlatinib ALK? It's much more like an OC.
S
24:24Stephen LiuGUEST
You're looking at about a year and a half in the frontline setting for PFS.
S
24:27Stephen LiuGUEST
So I think that right now that's what I lean towards.
Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
S
24:16Stephen LiuGUEST
And so it feels like a frontline drug to me.
S
24:18Stephen LiuGUEST
But if I had to sort of slot it, is it like an EGFR OC or is it like a Lorlatinib-ALC? It's much more like an OC.
S
24:24Stephen LiuGUEST
You're looking at about a year and a half in the frontline setting for PFS.
S
24:27Stephen LiuGUEST
So I think that right now, that's what I lean towards.